SEC Form 4 · accession 0001127602-15-004639
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Causey
Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 5, 2015 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 5, 2015 | M | 3,000 | $41.14 | A | 3,733 | D | |
| Common StockF3 | Feb 5, 2015 | S | 3,000 | $140.3968 | D | 733 | D | |
| Common StockF4 | holding | — | — | — | 450 | I | By Ugma Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $41.14 | Feb 5, 2015 | M | 3,000 | D | Jun 26, 2010 | Jun 26, 2019 | Common Stock | 3,000 | 10,500 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $140.20 to $141.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4Shares held in Uniform Gift to Minors Accounts for the benefit of the reporting person's children.